[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$feM1MdbyH9zUPMOzDrkx9WDCvTvd3gMi508iKKnCp--g":8,"$fP7J-VYgsZxk2Y6STzXnU6eXCL9DxsdGQVsj92K_pVs8":55,"$fkWtW93L41jpcVsaDDRkAbqCuLW3xNp43Ek32Xs_ik3Y":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},49128,867572,[],"https://ystcdn.venuertc.com/medical/ystApp/bDTdYP4imVrMXQF19mTwvfgYQHY8dTdF.png","李海燕","山西省肿瘤医院","呼吸内科","主治医师",32,0,"小细胞肺癌广泛期化疗与曲拉西利联合用药指南：关键细节全解析","","https://ystcdn.venuertc.com/venue/AI/d73f5301-4707-41f0-ae89-62e12a8e9d38.jpg","\u003Cdiv class=\"sclc-guide-wrap\">\n  \u003Ch1 id=\"material_title\" class=\"sclc-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    小细胞肺癌广泛期化疗与曲拉西利联合用药指南：关键细节全解析\n  \u003C/h1>\n  \n  \u003Cdiv class=\"sclc-section sclc-bg-1\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      01. 曲拉西利和化疗药物是什么？——核心要素一览 🧬\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cp>\n        曲拉西利（trilaciclib）是一种短效、可逆性的细胞周期蛋白依赖性激酶4/6（CDK4/6）抑制剂。它以静脉注射剂型用于化疗前，目的是保护骨髓造血功能。依托泊苷等化疗药物则直接针对肿瘤细胞进行杀伤。二者搭配使用，能提升患者对化疗的不良反应耐受性。\u003Cbr>\n        \u003Cspan class=\"sclc-highlight\">本文将详细梳理8大用药关键，包括：给药时间、用法用量、剂型要求、不良反应、药物相互作用、特殊人群、禁忌与储存，助你用药安心无忧。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sclc-section sclc-bg-2\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      02. 曲拉西利与化疗的作用机制——如何协同发挥疗效？ ⚙️\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cp>\n        曲拉西利属于细胞周期调控类药物。它通过暂时阻断骨髓造血细胞的细胞周期，使其停滞在G1期，暂时不被化疗药物杀伤；但肿瘤细胞通常不受此影响，依然进入分裂周期，被依托泊苷等化疗药“锁定”。曲拉西利的作用是“提前让健康骨髓细胞躲避一劫”，而不影响化疗的具体抗肿瘤作用。\n      \u003C/p>\n      \u003Cp>\n        数据显示，在广泛期小细胞肺癌一线治疗中，化疗前应用曲拉西利可显著降低严重中性粒细胞减少发生率和严重血液不良反应（Yang et al., 2021）。\n      \u003C/p>\n      \u003Cp class=\"sclc-note\">\n        \u003Cstrong>注：\u003C/strong>曲拉西利不直接抑瘤，也不会影响激素、免疫系统，主要是发挥骨髓保护作用。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sclc-section sclc-bg-3\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      03. 给药时间与正确方法——每一步不可疏忽 ⏱️\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>曲拉西利：\u003C/strong>需在每次化疗当天，\u003Cspan class=\"sclc-highlight\">化疗药物输入前30分钟到4小时内静脉滴注\u003C/span>，持续约30分钟，建议尽量靠近化疗药物给药时间。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>依托泊苷等化疗药物：\u003C/strong>严格在曲拉西利给药完成后，按主治医师制定的时序执行。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>饮水与饮食：\u003C/strong>曲拉西利为静脉注射，不需关注餐前餐后，但化疗用药当天应避免暴饮暴食和刺激性食物。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>静脉通道：\u003C/strong>必须由专业护理团队操作，防止药液外渗导致局部刺激。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"sclc-highlight\">\n          有位患者在化疗间隔后未及时按序输注曲拉西利，导致血液系统不良反应增加，说明用药时序的把控极为重要。\n        \u003C/span>\n      \u003C/p>\n      \u003Cp class=\"sclc-tips\">\n        正确做法：提前协调用药流程，严格配合医护通知的用药时间，不私自提前或延后。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sclc-section sclc-bg-4\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      04. 剂型与规格——怎么选、怎么用才正确？ 💉\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>曲拉西利:\u003C/strong>\n          \u003Cul>\n            \u003Cli>剂型为冻干粉针剂，需溶解后静脉滴注，不可口服或肌注。\u003C/li>\n            \u003Cli>常用规格为300mg/瓶。用量根据体表面积精准计算。\u003C/li>\n            \u003Cli>\n              溶解或稀释药液需使用医用无菌水并遵照说明书操作，严禁自行操作。\n            \u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>化疗药物（依托泊苷等）：\u003C/strong>\n          \u003Cul>\n            \u003Cli>也为静脉用制剂，与曲拉西利用不同输液通道给予。\u003C/li>\n            \u003Cli>配伍间隔、稀释要求应交由医师和药师把关。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"sclc-highlight\">正确做法：\u003C/span>患者及家属不应私自拆封、溶解或准备药物，须全程依托医护管理。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sclc-section sclc-bg-5\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      05. 剂量与用药周期——如何配合、怎样调整？ 📅\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>曲拉西利剂量：\u003C/strong>\n          \u003Cul>\n            \u003Cli>\n              成人用药需根据体表面积（mg/m\u003Csup>2\u003C/sup>）个体化计算，通常为240mg/m\u003Csup>2\u003C/sup>，每个化疗周期按医生调整剂量和注射次数。\n            \u003C/li>\n            \u003Cli>\n              不主张擅自加量或减量，也不可私自调整间隔。\n            \u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>化疗药物剂量：\u003C/strong>\n          \u003Cul>\n            \u003Cli>\n              由肿瘤专科医生根据具体方案（如依托泊苷日程）设定。\n            \u003C/li>\n            \u003Cli>\n              曲拉西利剂量与化疗计划密切相关，中断或变更化疗计划时，曲拉西利的用药策略也需一并调整。\n            \u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"sclc-tips\">正确做法：\u003C/span>\n        所有剂量调整均需经主治医师判定，不容“经验法则”替代。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sclc-section sclc-bg-6\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      06. 药物相互作用需警惕——这些药品不能随意同用 🚫\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cul>\n        \u003Cli>\n          曲拉西利主要通过肝脏代谢（CYP3A4途径），同时服用强效CYP3A4抑制剂或诱导剂（如某些抗结核药、部分抗癫痫药）可影响药效或风险。\n        \u003C/li>\n        \u003Cli>\n          接受卷曲拉西利联合化疗患者，避免叠加同类CDK4/6抑制剂使用，以免不良反应风险增加。\n        \u003C/li>\n        \u003Cli>\n          部分抗高血压药、抗真菌药或抗病毒药也可能干扰曲拉西利代谢，应主动告知医生所有用药历史。\n        \u003C/li>\n        \u003Cli>\n          辅助用药，如制酸剂、激素类药物等，应与化疗方案分开评估，不得自行叠加。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cspan class=\"sclc-highlight\">特别提醒：\u003C/span>如需调整任何正在服用的药物，务必让治疗团队知情，由医生综合评判调整方案。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sclc-section sclc-bg-7\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      07. 常见不良反应与处理办法——务必留意 🩸\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>曲拉西利不良反应：\u003C/strong> 注射部位反应（红肿痛）、轻度恶心、疲劳最常见。偶有轻度血压变化、发热或感染风险略增。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>化疗药物不良反应：\u003C/strong> 以骨髓抑制（如白细胞、血小板减少）、胃肠道反应为主。曲拉西利对这些反应有明确缓解作用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>处理措施：\u003C/strong>\n          出现注射部位红肿、强烈头晕、寒战等情况时，请立刻告知医护人员。恶心呕吐可以等候医师开具对症药物辅助。\n        \u003C/li>\n        \u003Cli>\n          临床研究报告，应用曲拉西利后≥3级中性粒细胞减少发生率约降低50%（Weiss et al., 2021）。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp class=\"sclc-alert\">\n        \u003Cspan class=\"sclc-highlight\">出现严重全身反应（如呼吸异常、高热、昏迷）时，务必立即就医。\u003C/span>\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sclc-section sclc-bg-8\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      08. 特殊人群用药与禁忌症——这些情况需特别注意 🎯\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>老年人：\u003C/strong> 剂量通常不变，但体能差的患者需加强用药安全监测。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝肾功能障碍者：\u003C/strong> 中重度肝损伤或肾损伤患者慎用，有用药需求时请医生进行个体化方案调整。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>孕妇与哺乳期妇女：\u003C/strong> 原则上禁用，因药物或代谢产物可能影响胎儿或乳婴安全。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>禁忌症：\u003C/strong> 对曲拉西利任一成分过敏者严禁使用。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cp>\n        \u003Cstrong>正确做法：\u003C/strong> 用药前必须如实告知医生自身健康状况及全部过敏史，怀孕和哺乳期必须声明。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sclc-section sclc-bg-9\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      09. 储存、用药遗忘与过量应对—细节守护安全 🔒\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>储存：\u003C/strong>\n          曲拉西利冻干粉宜密闭、避光、阴凉（2-8℃）保存，避免受潮、暴晒。稀释后药液要按说明在医用条件下尽快使用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>漏服：\u003C/strong>\n          如漏服，应尽快与医院联系，遵循医师安排补做，不可随意延后或提前使用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过量：\u003C/strong>\n          意外过量需立即就医，可能引发急性毒性反应。院内方可进行抢救与对症处理。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>药品安全：\u003C/strong>\n          未用完或过期的瓶装药物需按医疗废弃物标准处理，不可自行丢弃。\n        \u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"sclc-section sclc-bg-10\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      10. 小结与合理用药建议 📝\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content\">\n      \u003Cp>\n        曲拉西利联合化疗，是提升广泛期小细胞肺癌化疗依从性与安全性的创新组合。\u003Cspan class=\"sclc-highlight\">曲拉西利强调化疗前短程静脉输注，按体表面积个体化用量。它与多种药物有相互作用风险，患者当前药品信息必须完全向医生披露。\u003C/span>\n      \u003C/p>\n      \u003Cp>\n        骨髓保护与不良反应减轻是联合用药的最大亮点，但用药时间、剂量和禁忌要求严格。一切与用药相关的问题，请及时向主治医师、药师咨询，切勿擅自调整，任何异常反应务必第一时间反馈。\n      \u003C/p>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"sclc-section sclc-bg-ref\">\n    \u003Ch2 class=\"sclc-subtitle\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n      参考文献\n    \u003C/h2>\n    \u003Cdiv class=\"sclc-content sml-sclc-list\">\n      \u003Col>\n        \u003Cli>\n          Yang, S., et al. (2021). Trilaciclib before chemotherapy reduces the incidence of chemotherapy-induced myelosuppression in patients with extensive-stage small-cell lung cancer: A randomized Phase 2 study. \u003Ci>Journal of Clinical Oncology\u003C/i>, 39(8), 906-915.\n        \u003C/li>\n        \u003Cli>\n          Weiss, J. M., et al. (2021). Effect of trilaciclib administered prior to chemotherapy on myelosuppression in patients with extensive-stage small-cell lung cancer: Results from a randomized, double-blind, placebo-controlled phase II trial. \u003Ci>Annals of Oncology\u003C/i>, 32(5), 687-697.\n        \u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.sclc-guide-wrap {\n  font-family: 'Segoe UI', 'PingFang SC', 'Helvetica Neue', Arial, 'Microsoft YaHei', sans-serif;\n  background: #f7fafc;\n  padding: 36px 12px 44px 12px;\n  max-width: 840px;\n  margin: 0 auto;\n  box-shadow: 0 2px 20px rgba(100,120,140,0.07);\n  border-radius: 16px;\n}\n.sclc-title {\n  font-size: 2.3em;\n  color: #124166;\n  text-align: center;\n  font-weight: 700;\n  margin-bottom: 38px;\n  letter-spacing: 1.5px;\n}\n.sclc-section {\n  margin-bottom: 38px;\n  border-radius: 10px;\n  box-shadow: 0 1px 6px rgba(180,195,220,0.07);\n  padding: 0 22px 19px 22px;\n  background: #fff;\n  position: relative;\n}\n.sclc-subtitle {\n  font-size: 1.35em;\n  color: #19506d;\n  background: linear-gradient(94deg, #deecfd 75%, rgba(196,231,243,0.5)), url(\"data:image/gif;base64,R0lGODlhAQABAAD/ACwAAAAAAQABAAACADs=\"); /* 轻描淡写背景 */\n  border-left: 6px solid #7ab1de;\n  border-radius: 0 7px 7px 0;\n  padding: 13px 0 13px 18px;\n  margin-left: -22px;\n  margin-right: -22px;\n  margin-bottom: 16px;\n  font-weight: 600;\n  position: relative;\n}\n.sclc-content {\n  font-size: 1.12em;\n  color: #293d4d;\n  line-height: 1.96;\n  margin-top: 7px;\n}\n.sclc-bg-1 { background: linear-gradient(92deg, #e9f2ff 57%, #f6fcfe 95%); }\n.sclc-bg-2 { background: linear-gradient(97deg, #e5f9f3 57%, #fbfafc 100%); }\n.sclc-bg-3 { background: linear-gradient(95deg, #f8ebfa 57%, #fdfafb 100%); }\n.sclc-bg-4 { background: linear-gradient(96deg, #e5f6fc 57%, #f6fdfc 100%); }\n.sclc-bg-5 { background: linear-gradient(95deg, #f1f7e2 57%, #fffef6 100%); }\n.sclc-bg-6 { background: linear-gradient(93deg, #fff3e4 57%, #faf2f9 97%); }\n.sclc-bg-7 { background: linear-gradient(95deg, #fcebe4 57%, #fffdfc 100%); }\n.sclc-bg-8 { background: linear-gradient(102deg, #e2eaff 37%, #f8fafd 100%); }\n.sclc-bg-9 { background: linear-gradient(91deg, #eff0f9 67%, #f9fbfc 100%); }\n.sclc-bg-10 { background: linear-gradient(97deg, #f8f8f8 65%, #ecf7fa 100%); }\n.sclc-bg-ref { background: linear-gradient(93deg, #ebf2fa 57%, #eefbfc 100%);}\n.sclc-highlight {\n  background: #e0f7ff;\n  padding: 2px 7px;\n  border-radius: 5px;\n  color: #1179b0;\n  font-weight: 600;\n}\n.sclc-note {\n  background: #fffbe7;\n  border-left: 4px solid #d2b773;\n  padding: 4px 10px;\n  margin: 10px 0;\n  border-radius: 4px;\n  color: #94631a;\n}\n.sclc-tips {\n  background: #e7faef;\n  border-left: 4px solid #50c487;\n  padding: 4px 10px;\n  margin: 10px 0;\n  border-radius: 4px;\n  color: #23704e;\n  font-style: italic;\n}\n.sclc-alert {\n  background: #fff0f0;\n  border-left: 4px solid #dc6b6b;\n  padding: 5px 10px;\n  margin: 13px 0;\n  border-radius: 4px;\n  color: #ba2323;\n  font-weight: 600;\n}\n.sml-sclc-list {\n  padding-left: 18px;\n}\n.sml-sclc-list li {\n  padding: 3px 0;\n}\n@media (max-width: 700px) {\n  .sclc-guide-wrap { padding: 13px 0 18px 0;}\n  .sclc-title { font-size: 1.38em;}\n  .sclc-section { padding: 0 8px 13px 8px; }\n  .sclc-subtitle { font-size: 1.08em; padding: 10px 0 10px 10px; margin-left:-8px; margin-right:-8px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"sclc-guide-wrap\">\n  \u003Ch1 id=\"material_title\" class=\"sclc-title\" style=\"color: rgb(44, 62,",528,"2025-07-15 14:54:54","小细胞肺癌, 曲拉西利, 化疗药物, 药物相互作用, 不良反应","本指南为广泛期小细胞肺癌患者提供曲拉西利与化疗联合用药的全面信息，让您了解用药时机、剂量调整及不良反应管理，确保安全有效的治疗。","2025-07-17 19:14:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]